Pneumococcal vaccination in Europe

Schedule adherence

Alain Gervaix, Filippo Ansaldi, António Brito-Avô, Chiara Azzari, Markus Knuf, Federico Martinón-Torres, David Tuerlinckx, Myint Tin Tin Htar, George A. Syrogiannopoulos

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the primary PCV and booster series) in different European countries. We found that adherence with the PCV schedule was lower than that for diphtheria-tetanus-acellular pertussis (DTaP) and that higher adherence was observed in countries where PCV vaccination is recommended and funded. Adherence with the booster dose is often lower than that with the primary series completion, and it is often given after the recommended age. These data highlight the need to encourage timely vaccination of children with PCV, in line with local immunization schedules. There is no single solution to improve adherence; actions need to be tailored to the context of individual countries through initiatives at the national, regional, and local levels and should target different stakeholders.

Original languageEnglish
JournalClinical Therapeutics
Volume36
Issue number5
DOIs
Publication statusPublished - May 1 2014

Fingerprint

Conjugate Vaccines
Pneumococcal Vaccines
Appointments and Schedules
Vaccination
Immunization Schedule
Diphtheria
Whooping Cough
Tetanus

Keywords

  • pneumococcal conjugate vaccine
  • Streptococcus pneumoniae
  • vaccination schedule adherence
  • vaccine uptake

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Medicine(all)

Cite this

Gervaix, A., Ansaldi, F., Brito-Avô, A., Azzari, C., Knuf, M., Martinón-Torres, F., ... Syrogiannopoulos, G. A. (2014). Pneumococcal vaccination in Europe: Schedule adherence. Clinical Therapeutics, 36(5). https://doi.org/10.1016/j.clinthera.2014.03.001

Pneumococcal vaccination in Europe : Schedule adherence. / Gervaix, Alain; Ansaldi, Filippo; Brito-Avô, António; Azzari, Chiara; Knuf, Markus; Martinón-Torres, Federico; Tuerlinckx, David; Tin Htar, Myint Tin; Syrogiannopoulos, George A.

In: Clinical Therapeutics, Vol. 36, No. 5, 01.05.2014.

Research output: Contribution to journalArticle

Gervaix, A, Ansaldi, F, Brito-Avô, A, Azzari, C, Knuf, M, Martinón-Torres, F, Tuerlinckx, D, Tin Htar, MT & Syrogiannopoulos, GA 2014, 'Pneumococcal vaccination in Europe: Schedule adherence', Clinical Therapeutics, vol. 36, no. 5. https://doi.org/10.1016/j.clinthera.2014.03.001
Gervaix A, Ansaldi F, Brito-Avô A, Azzari C, Knuf M, Martinón-Torres F et al. Pneumococcal vaccination in Europe: Schedule adherence. Clinical Therapeutics. 2014 May 1;36(5). https://doi.org/10.1016/j.clinthera.2014.03.001
Gervaix, Alain ; Ansaldi, Filippo ; Brito-Avô, António ; Azzari, Chiara ; Knuf, Markus ; Martinón-Torres, Federico ; Tuerlinckx, David ; Tin Htar, Myint Tin ; Syrogiannopoulos, George A. / Pneumococcal vaccination in Europe : Schedule adherence. In: Clinical Therapeutics. 2014 ; Vol. 36, No. 5.
@article{a46711288d6b4aeab52f6787ff9269a2,
title = "Pneumococcal vaccination in Europe: Schedule adherence",
abstract = "Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the primary PCV and booster series) in different European countries. We found that adherence with the PCV schedule was lower than that for diphtheria-tetanus-acellular pertussis (DTaP) and that higher adherence was observed in countries where PCV vaccination is recommended and funded. Adherence with the booster dose is often lower than that with the primary series completion, and it is often given after the recommended age. These data highlight the need to encourage timely vaccination of children with PCV, in line with local immunization schedules. There is no single solution to improve adherence; actions need to be tailored to the context of individual countries through initiatives at the national, regional, and local levels and should target different stakeholders.",
keywords = "pneumococcal conjugate vaccine, Streptococcus pneumoniae, vaccination schedule adherence, vaccine uptake",
author = "Alain Gervaix and Filippo Ansaldi and Ant{\'o}nio Brito-Av{\^o} and Chiara Azzari and Markus Knuf and Federico Martin{\'o}n-Torres and David Tuerlinckx and {Tin Htar}, {Myint Tin} and Syrogiannopoulos, {George A.}",
year = "2014",
month = "5",
day = "1",
doi = "10.1016/j.clinthera.2014.03.001",
language = "English",
volume = "36",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica Inc.",
number = "5",

}

TY - JOUR

T1 - Pneumococcal vaccination in Europe

T2 - Schedule adherence

AU - Gervaix, Alain

AU - Ansaldi, Filippo

AU - Brito-Avô, António

AU - Azzari, Chiara

AU - Knuf, Markus

AU - Martinón-Torres, Federico

AU - Tuerlinckx, David

AU - Tin Htar, Myint Tin

AU - Syrogiannopoulos, George A.

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the primary PCV and booster series) in different European countries. We found that adherence with the PCV schedule was lower than that for diphtheria-tetanus-acellular pertussis (DTaP) and that higher adherence was observed in countries where PCV vaccination is recommended and funded. Adherence with the booster dose is often lower than that with the primary series completion, and it is often given after the recommended age. These data highlight the need to encourage timely vaccination of children with PCV, in line with local immunization schedules. There is no single solution to improve adherence; actions need to be tailored to the context of individual countries through initiatives at the national, regional, and local levels and should target different stakeholders.

AB - Nonadherence to recommended pneumococcal conjugate vaccine (PCV) schedules may have implications for protection against pneumococcal disease. In this commentary, we have assessed adherence to the recommended dosing schedules (the completion of the primary PCV and booster series) in different European countries. We found that adherence with the PCV schedule was lower than that for diphtheria-tetanus-acellular pertussis (DTaP) and that higher adherence was observed in countries where PCV vaccination is recommended and funded. Adherence with the booster dose is often lower than that with the primary series completion, and it is often given after the recommended age. These data highlight the need to encourage timely vaccination of children with PCV, in line with local immunization schedules. There is no single solution to improve adherence; actions need to be tailored to the context of individual countries through initiatives at the national, regional, and local levels and should target different stakeholders.

KW - pneumococcal conjugate vaccine

KW - Streptococcus pneumoniae

KW - vaccination schedule adherence

KW - vaccine uptake

UR - http://www.scopus.com/inward/record.url?scp=84901469473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901469473&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2014.03.001

DO - 10.1016/j.clinthera.2014.03.001

M3 - Article

VL - 36

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - 5

ER -